Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125068972 | 12506897 | 2 | F | 20160629 | 20160629 | 20160714 | EXP | IT-CIPLA LTD.-2016IT07407 | CIPLA | 0.00 | Y | 0.00000 | 20160714 | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125068972 | 12506897 | 1 | PS | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | 25 MG/KG, UNK | U | U | 77383 | 25 | MG/KG | ||||||
| 125068972 | 12506897 | 2 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | 50 MG/KG, DAILY | U | U | 77383 | 50 | MG/KG | ||||||
| 125068972 | 12506897 | 3 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | 80 MG/KG, UNK | U | U | 0 | 80 | MG/KG | ||||||
| 125068972 | 12506897 | 4 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | 50 MG/KG, UNK | U | U | 0 | 50 | MG/KG | ||||||
| 125068972 | 12506897 | 5 | SS | Vincristine | VINCRISTINE | 1 | Unknown | 0.04 MG/KG, UNK | U | U | 0 | .04 | MG/KG | ||||||
| 125068972 | 12506897 | 6 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | 135 MG/KG, UNK | U | U | 0 | 135 | MG/KG | ||||||
| 125068972 | 12506897 | 7 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 250 MG/KG,UNK | U | U | 0 | 250 | MG/KG | ||||||
| 125068972 | 12506897 | 8 | SS | Melphalan | MELPHALAN | 1 | Unknown | 4 MG/KG, DAILY | U | U | 0 | 4 | MG/KG | ||||||
| 125068972 | 12506897 | 9 | SS | THIOTEPA. | THIOTEPA | 1 | Unknown | 10 MG/KG, QD | U | U | 0 | 10 | MG/KG | ||||||
| 125068972 | 12506897 | 10 | C | Granulocyte-Colony stimulating factor (G-CSF) | 2 | Unknown | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125068972 | 12506897 | 1 | Glioblastoma multiforme |
| 125068972 | 12506897 | 3 | Glioblastoma multiforme |
| 125068972 | 12506897 | 5 | Glioblastoma multiforme |
| 125068972 | 12506897 | 6 | Glioblastoma multiforme |
| 125068972 | 12506897 | 7 | Glioblastoma multiforme |
| 125068972 | 12506897 | 8 | Glioblastoma multiforme |
| 125068972 | 12506897 | 9 | Glioblastoma multiforme |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125068972 | 12506897 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125068972 | 12506897 | Anaemia | |
| 125068972 | 12506897 | Juvenile melanoma benign | |
| 125068972 | 12506897 | Thrombocytopenia | |
| 125068972 | 12506897 | Transaminases increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |